The WHO’s latest alert against three Indian-made cough syrups – Coldrif, Respifresh TR, and ReLife – marks yet another grim ...
Travel within Africa is often expensive, difficult and poorly connected. But investment in aviation could offer huge ...
In the early 2000s, Cipla’s breakthrough in HIV treatment and low-cost antiretroviral (ARV) drugs positioned Indian pharma as ...
Business and Financial Times on MSN
GoldBod's model seen as Africa's next policy export
Government’s strategy for managing the country’s gold resources is attracting growing regional attention – with finance ...
When I worked in The Gambia, I watched parents weep as their children slipped away from a mysterious illness. The hospitals ...
NDTV Profit on MSN
WHO Warns Against Three India-Made Cough Syrups After Child Deaths
The tainted products were found in specific batches of COLDRIF, Respifresh TR and ReLife manufactured by Sresan ...
5don MSNOpinion
India’s drug regulation is stuck in a time warp
Calls for tighter government oversight are justified, yet regulation alone may not suffice in a system vulnerable to ...
The Business & Financial Times on MSNOpinion
Editorial: GOLDBOD praised for ethical resource governance
Finance ministers from five African countries have praised government’s strategy for managing the country’s gold resources.
The deaths of 24 children in Madhya Pradesh after consuming tainted Coldrif cough syrup reveal the deep rot in India’s ...
The poisoning of children in Madhya Pradesh state has sparked urgent calls to reform India's massive pharmaceutical industry, ...
That’s the resounding message from the 2025 Africa CEO Trade Survey, unveiled in Geneva on Thursday September 18, 2025, by the Pan-African Private Sector Trade and Investment Committee (PAFTRAC) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback